Apart from that, the research house opined that the additional supply from new entrants to the glove manufacturing industry is not a concern at present.

For one, new entrants will likely struggle to secure already-tight nitrile butadiene rubber (NBR) supply - an issue plaguing glove producers.

“Furthermore, it may take up to 1½ years to complete the glove manufacturing facilities.

“By 2022, supply from new entrants which is estimated at a blue-sky capacity of 29.4 billion pieces annually represents 6% of global glove demand of 485 billion pieces, ” it said.

UOB Kay Hian has raised its financial year 2021 to 2022 net profit forecasts for Supermax Corp Bhd by 216% and 505%, respectively, in line with updated ASPs, output and cost assumptions.

The research house added that the gradual ramp-up in the global manufacturing of Covid-19 vaccine would mean that the average selling prices (ASPs) of gloves are unlikely to fall sharply immediately.

UOB Kay Hian said that the Covid-19 vaccine candidate’s achievement of 90% efficacy was within expectations, noting that an additional 12 to 18 months were required to achieve global herd immunity.


“To reiterate, it (vaccine update) does not fundamentally affect glove demand over 2021 as we believe supply is still in severe shortage with usage rate exceeding the glove production rate.

“Furthermore, it would take an additional six to nine months to fully restock the entire supply chain.

According to UOB Kay Hian, Supermax Corp Bhd’s capacity has been sold up until end-2021 and the group is receiving deposits at 30% to 50% of contracted orders.

Wednesday, 11 Nov 2020

Outlook of glove makers seen unaffected near term

https://www.thestar.com.my/business/business-news/2020/11/11/outlook-of-glove-makers-seen-unaffected-near-term

PETALING JAYA: The updates on the Covid-19 vaccine development are not expected to affect the prospects of glove makers in the near term.

An analyst noted that forecasts for glove companies remained unchanged and estimated that local glove makers generally have orders secured up until the end of 2021.

According to UOB Kay Hian, Supermax Corp Bhd’s capacity has been sold up until end-2021 and the group is receiving deposits at 30% to 50% of contracted orders.

Meanwhile, Kossan Rubber Industries Bhd’s capacity has been fully taken up until the end of 2021 while still receiving orders for 2022.

UOB Kay Hian said that the Covid-19 vaccine candidate’s achievement of 90% efficacy was within expectations, noting that an additional 12 to 18 months were required to achieve global herd immunity.


“To reiterate, it (vaccine update) does not fundamentally affect glove demand over 2021 as we believe supply is still in severe shortage with usage rate exceeding the glove production rate.

“Furthermore, it would take an additional six to nine months to fully restock the entire supply chain.

“Based on previous recent sell-downs, there could be a 20% to 30% knee-jerk selling, which could be a meaningful entry, given that the prospects are intact, ” said UOB Kay Hian in a recent report on Supermax.

The research house added that the gradual ramp-up in the global manufacturing of Covid-19 vaccine would mean that the average selling prices (ASPs) of gloves are unlikely to fall sharply immediately.

UOB Kay Hian has raised its financial year 2021 to 2022 net profit forecasts for Supermax Corp Bhd by 216% and 505%, respectively, in line with updated ASPs, output and cost assumptions.

It said key risks to the earnings revision include the strengthening of the Ringgit against the US dollar and a potential windfall tax.

“In the recently tabled Budget 2021 on Nov 6, it was announced that the Big Four glove producers have committed to donate a cumulative RM400mil to help ease the government’s burden for vaccine and health equipment expenses.

“We are positive over the development as this rests rumours of a potential windfall tax, ” said UOB Kay Hian.

Apart from that, the research house opined that the additional supply from new entrants to the glove manufacturing industry is not a concern at present.

For one, new entrants will likely struggle to secure already-tight nitrile butadiene rubber (NBR) supply - an issue plaguing glove producers.

“Furthermore, it may take up to 1½ years to complete the glove manufacturing facilities.

“By 2022, supply from new entrants which is estimated at a blue-sky capacity of 29.4 billion pieces annually represents 6% of global glove demand of 485 billion pieces, ” it said.

Pfizer Inc. (PFE)

NYSE - Currency in USD

38.68-0.52 (-1.33%)

At close: 4:02PM EST

Bye bye Djoker89

See you at RM15

Mercator WA (MRCP)

516.00 +8.00 +1.57%

https://www.investing.com/equities/mercator-wa

SPMXF:USOTC US

Supermax Corp Bhd

2.13USD+0.07+3.40%

Top Glove Corporation Bhd. (TGLVY)

7.30+0.24 (+3.40%)

As of 10:00AM EST. Market open.

https://finance.yahoo.com/quote/TGLVY/

WOW~ Like that based on @DJoker89 logic tomorrow Supermax will fly -20%/ -2% = 10 times!!!!!!!!!!

RM 8.83 x 10 times!!!!!!!!!! = RM 88.3 it’s quite reasonable

‘Nah, give you another vaccine news

NOVEMBER 10, 20207:35 PMUPDATED 2 HOURS AGO

Medicago's COVID-19 vaccine triggers immune response in early-stage trial

https://www.reuters.com/article/health-coronavirus-medicago-vaccine/medicagos-covid-19-vaccine-triggers-immune-response-in-early-stage-trial-idUSKBN27Q1IB

Happy?


MORE VACCINES MORE GLOVE DEMAND

More gloves will be needed for Testing and Vaccination

currently Global shortfall of more than 200 billion Nitrile gloves to handle 51 Million cases worldwide

to vaccinate 7.8 billion world population

Global shortfall of Nitrile gloves will explode to 3,058.8 billion Nitrile gloves

(7,800 Million / 51 Million x 200 Billion Nitrile gloves = 30,588 billion Nitrile gloves
Let’s take 10% only then 30,588 billion Nitrile gloves x 10% = 3,058.8 billion Nitrile gloves)

and if the immunity of the vaccine only lasts for one year then you count yourself lo

Since you have So Much Concerns so Negative on Supermax

Then WHY YOU ARE STILL HERE leh..??

Sold already time to go away Get Lost ahhhh...

when Effective and Safe vaccine is available to the public in the 2nd half of 2021

More gloves will be needed for Testing and Vaccination

currently Global shortfall of more than 200 billion Nitrile gloves to handle 51 Million cases worldwide

to vaccinate 7.8 billion world population

Global shortfall of Nitrile gloves will explode to 3,058.8 billion Nitrile gloves

(7,800 Million / 51 Million x 200 Billion Nitrile gloves = 30,588 billion Nitrile gloves
Let’s take 10% only then 30,588 billion Nitrile gloves x 10% = 3,058.8 billion Nitrile gloves)

and if the effectiveness of the vaccine only lasts for one year then you count yourself lo

Author: Koon Yew Yin | Publish date: Tue, 10 Nov 2020, 5:47 PM

https://klse.i3investor.com/blogs/koonyewyinblog/

Medical workers must wear gloves to inject vaccines and to test coronavirus - Koon Yew Yin

When vaccines are proven safe for use, more medical workers will be employed and all of them are required to wear gloves. As a result, more gloves are required as shown in the photos above.

Due to Covid 19 pandemic the demand for medical gloves will continue to exceed supply and all the glove makers are increasing their selling prices to make more and more profit.

global shortfall of more than 200 billion Nitrile gloves

global shortfall of more than 200 billion Nitrile gloves

global shortfall of more than 200 billion Nitrile gloves

Today tomorrow Up or down will not change the fact that

Trump admin is 'woefully behind' in stockpiling medical gloves as Covid-19 surges

https://www.nbcnews.com/politics/politics-news/trump-admin-woefully-behind-stockpiling-medical-gloves-covid-19-surges-n1245298

Nitrile gloves are critical for frontline medical workers, but experts say the U.S. is poorly positioned to get ahead of a global shortfall of more than 200 billion.

The last time was expecting Coronavirus cases will hit 50 Million by end of the year

But today it’s already hit more than 51 Million cases worldwide!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Almost 2 months earlier than expected

OMG!!! VERY FIERCE VIRUS!! SO SCARY!!!

https://www.worldometers.info/coronavirus/#countries

Coronavirus Cases:
51,345,047

Deaths:
1,271,129

It’s not even Winter yet! This is going to be a very Cold DARK Winter


Joe Biden has no executive power now will only take White House office officially on 20 January 2021 that he may not be able to do anything significant until then, by then could be over 100 Million cases already…

Whatever the Nonsenses craps Regardless how much Noises lies to spread fears

Trust only Profit

Trust only Real Profit = Money

Trust only Supermax ALREADY making HUGE PROFIT right now While You Are Trolling
while you are breathing while you are sleeping

Super strong fundamentals of Supermax OBM-X business model Own Distribution Network will prevail

Each rubbish word trolls type EVERY MINUTE trolls are trolling, Supermax is ALREADY making ≥ RM 8K to 10K for loyal shareholders

Supermax is ALREADY earning ≥ PAT Half a Million ringgit EVERY HOUR while you’re trolling

Supermax is ALREADY making ≥ Profit After Tax RM 10 – 15 Million EVERYDAY while you’re trolling

Supermax is superb strong does not need share buyback to support

Anyway it’s good too if Supermax buyback some shares to list on SGX

What’s the possible benefit for those trolls naysayers liars sourgrapes psychopath rats cockroaches spread fears scare you to sell?

1. They want to buy, Buyback or buy more SUPERMX shares from you.
OTHERWISE, THEY’LL NOT BE HERE.
OTHERWISE, THEY’LL NOT BE HERE.
OTHERWISE, THEY’LL NOT BE HERE.

2. No benefit to them at all.
They are psychopath just mentally ill sick people. They keep asking people to sell here and there. They never buy share and will not buy any share. They are always losers. They are forever pathetic.

3. They want you to sell and move to their counters they have no confidence at all that they come here barking. WHY? Because there’s no other stock better than SUPERMX has reported Huge Profit PAT RM 812 Million (RM 812,485,000!!!!!!!!!) Amazing PBT Margin 77.6%!!! Prepayment received from customers 1.161 Billion PROFIT VISIBILITY!!! The Highest EPS 30.58 sen OBM-X Glove Maker!!!

4. They are the Pok Gai rats and cockroaches cyber warriors aka Net Army hired by crook evil IBs to spread fears scare you to manipulate the sickest stock market in the world Bursa.

Supermax achieved phenomenal amazing EBITDA, PBT and PAT margins of 78.8%, 77.6% and 60.1%, respectively

Even if cut by half the profit % you also can hardly find other Bursa companies can match ok??

Supermax

Prepayment received 30%, 40%, 50% from customers increased from RM 829 Million to RM 1,161 Million
( RM 1,161 Million / RM 829 Million = 140%)


OMG so Delicious!!! RM 1.161 Billion (RM 1,161,000,000) Cash received in advance from customers


Tell me which other Bursa company let you see such Crystal Clear Steady Earnings Visibility for the next one year lead time


RM 1,161 Million / 50% = RM 2,322 Million = RM 2.3 Billion revenue Guaranteed for the next one year! AMAZING
RM 2,322 Million / 4 Quarters = RM 580.5 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL


RM 1,161 Million / 40% = RM 2,902.5 Million = RM 2.9 Billion revenue Guaranteed for the next one year! AMAZING
RM 2,902.5 Million / 4 Quarters = RM 725.625 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL


RM 1,161 Million / 30% = RM 3,870 Million = RM 3.9 Billion revenue Guaranteed for the next one year! AMAZING
RM 3,870 Million / 4 Quarters = RM 967.5 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL



Spot orders USD 250/carton sold out for the next 3 months

Merkel cannot do anything about Coronavirus now lockdown again

Macron cannot do anything about Coronavirus now lockdown again

Trump has been ousted by Coronavirus

Do you think Biden has no executive power now will officially take White House Office only on 20 Jan 2021 can do anything about Coronavirus in Cold DARK WINTER Flu season??

Coronavirus1 hour ago (Nov 09, 2020 08:36PM ET)

China Vaccine Trial Halted After Serious Adverse Event

https://www.investing.com/news/coronavirus/china-vaccine-trial-halted-after-serious-adverse-event-2344388

(Bloomberg) -- The final-stage trial of a Chinese frontrunner vaccine candidate Sinovac Biotech Ltd.’s vaccine, called Coronavac, has been halted in Brazil after an event that occurred on Oct. 29, said the Brazil Health Agency on Tuesday, without any further detail on the illness. The study is interrupted in accordance with regulations while the agency analyzes if the study should continue, it said.

Serious adverse events that occur in drug trials include death, immediate risk of death, long term or serious incapacitation, and hospitalization.

Vaccine development processes that usually take years have been compressed into months by global players, encouraged by politicians wanting a quick fix to the pandemic that has sickened more than 50 million.

Surgical glove makers struggle to keep pace with booming demand

US-based Allied Market Research estimates that the global disposable gloves market amounted to $6.8 billion in 2019, and is expected to nearly triple to $18.8 billion by 2027.


https://www.thesundaily.my/world/surgical-glove-makers-struggle-to-keep-pace-with-booming-demand-DK3851849

PARIS: With no end in sight to the coronavirus pandemic, worldwide demand for surgical gloves -- as for other types of personal protective equipment -- is booming, leaving manufacturers struggling to keep up.

The global PPE market -- from masks, gowns and gloves, to shoes and sanitising gels -- is expected to balloon from $52 billion in 2019 to $93 billion in 2027, according to German market data specialist, Statista.

And, like other such products that were previously predominantly the domain of specialist medical personnel, the surgical glove has become much sought after even by the general public.

09 Nov 2020 11:53PM

https://www.channelnewsasia.com/news/world/covid-19-russia-sputnik-v-vaccine-more-than-90-effective-13501936

Russia's Sputnik V vaccine more than 90% effective: Health ministry

Russia confirmed 21,798 new coronavirus cases — a new one-day record and the fourth day in a row where new infections passed 20,000 — and 256 deaths.

There is no Effective and Safe vaccine approved by WHO yet. Period.

There is no vaccine company in Malaysia. Period.

Not a single cent of profit from re-bottling vaccine don’t know until when yet those gamblers speculators goreng up pharma counters again and again

Effective vaccine took 7 – 10 years to develop and often never found.

Who is responsible? Who’s liable if anything goes wrong with the shortcut ineffective “vaccine”??

what's the insurance??

The patients suffer harmful lifelong side effects can sue who?? those pharma counters??
Government?? The foreign vaccine companies??

How much you compensate also no use because the damage is already done!

Unless the vaccine CEO and their families take the vaccine “Live” on TV, on the then I’ll consider

One year later if they’re ok then I’ll consider again.

The ceiling price set for the Covid-19 vaccine offered to Malaysia under the Covax facility is US$21 (RM87.50) each, he added.

Do you think Government and Rakyat will let you profit more than 5%??

Half of USA people are die-hard Trump fans not willing to take vaccine because it’s a hoax

Even if Effective and Safe vaccine is found today it could take 10 years to vaccinate world population of 7.8 billion

Meanwhile, doctors, nurses, frontlines, scientists, etc. will stop using gloves?? It’s new norm, wake up

Previously only Developed countries use gloves but now Developing countries also use gloves

Great window of Opportunity for Fund Managers to re-balance their Local Funds, Foreign Funds, ETFs, etc, into Supermax inclusion into KLCI next week

Assuming Supermax OBM-X business model
• No more increase of ASP
• No more increase of Stunning net profit margin 60.07% (PBT Margin 77.6%)
• No inclusion into KLCI sure command higher PE valuation
• No Beyondmask in Canada No other PPE income
• No increase of new line production
• No increase of exports of production under own brands own distribution centres
• No expansion in UK and US
• No dual listing on SGX
• No increase of Net Cash whopping RM2.36 billion to next QR possibly 4b


EPS/Qr___Forward4Q___EPS/Yr______P/E______Fair Value______Fair Value discount 30%
30.58______4.00______122.32______20.00______RM 24.46______RM 17.12

30.58______4.00______122.32______25.00______RM 30.58______RM 21.41

30.58______4.00______122.32______30.00______RM 36.70______RM 25.69

30.58______4.00______122.32______35.00______RM 42.81______RM 29.97

30.58______4.00______122.32______40.00______RM 48.93______RM 34.25

Prepayment received 30%, 40%, 50% from customers increased from RM 829 Million to RM 1,161 Million
( RM 1,161 Million / RM 829 Million = 140%)


OMG so Delicious!!! RM 1.161 Billion (RM 1,161,000,000) Cash received in advance from customers


Tell me which other Bursa company let you see such Clear Stable Earnings Visibility for the next one year lead time


RM 1,161 Million / 50% = RM 2,322 Million = RM 2.3 Billion revenue Guaranteed for the next one year! AMAZING
RM 2,322 Million / 4 Quarters = RM 580.5 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL


RM 1,161 Million / 40% = RM 2,902.5 Million = RM 2.9 Billion revenue Guaranteed for the next one year! AMAZING
RM 2,902.5 Million / 4 Quarters = RM 725.625 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL


RM 1,161 Million / 30% = RM 3,870 Million = RM 3.9 Billion revenue Guaranteed for the next one year! AMAZING
RM 3,870 Million / 4 Quarters = RM 967.5 Million per quarter revenue Guaranteed for the next 4 quarters! WONDFERFUL

Supermax has whopping 2.36 Billion of cash can do whatever needed
Rm 2,360,000,000

Supermax will just Buyback all the shares to list on SGX

Medical gloves are now five times more expensive

Medical gloves are now five times more expensive

Medical gloves are now five times more expensive

Growing concern over shortage of medical gloves amid pandemic

https://www.nbcnews.com/nightly-news/video/growing-concern-over-shortage-of-medical-gloves-amid-pandemic-94964293524

$1 million worth of gloves were stolen from a Florida warehouse this week. Medical gloves in South Dakota are now five times more expensive, as public health officials fear a looming shortage.

global shortfall of more than 200 billion

global shortfall of more than 200 billion

global shortfall of more than 200 billion

Trump admin is 'woefully behind' in stockpiling medical gloves as Covid-19 surges

https://www.nbcnews.com/politics/politics-news/trump-admin-woefully-behind-stockpiling-medical-gloves-covid-19-surges-n1245298

Nitrile gloves are critical for frontline medical workers, but experts say the U.S. is poorly positioned to get ahead of a global shortfall of more than 200 billion.

The industry cannot meet the 120b of additional demand for gloves. This demand can only be fulfilled in three years, he adds.

Hartalega Holdings Bhd says demand for rubber gloves won’t be affected by vaccines for the Covid-19 coronavirus and will continue to outstrip supply in the next three to four years.

Hartalega sees no glove oversupply, unaffected by vaccine

https://www.thestar.com.my/business/business-news/2020/09/15/hartalega-sees-no-glove-oversupply-unaffected-by-vaccine

KUALA LUMPUR: Hartalega Holdings Bhd says demand for rubber gloves won’t be affected by vaccines for the Covid-19 coronavirus and will continue to outstrip supply in the next three to four years.

The pandemic has changed users’ behavior, that has resulted in the demand for gloves, chairman Kuan Kam Hon told reporters. Demand for usage in developed countries have increased 30% while in developing countries, usage has more than doubled, he says.

The industry cannot meet the 120b of additional demand for gloves. This demand can only be fulfilled in three years, he adds.

Spot prices for gloves have jumped 30% this quarter and he expects them to increase 40-50% in coming quarters, he says.

Glove prices are now three times higher compared to those during pre-covid-19.


Hartalega earmarked RM1.5bil investment to build four plants, of which first two lines will be operational by October 2021.

Another RM3bil is for its next expansion phase, its so-called NGC2, which will be fully completed in seven years. - Bloomberg